ClearPoint Neuro, Inc.
CLPT
$10.00
-$0.40-3.85%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 32.24M | 31.39M | 30.43M | 28.07M | 26.16M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 32.24M | 31.39M | 30.43M | 28.07M | 26.16M |
| Cost of Revenue | 12.51M | 12.27M | 12.06M | 11.27M | 11.22M |
| Gross Profit | 19.73M | 19.12M | 18.37M | 16.80M | 14.94M |
| SG&A Expenses | 28.26M | 26.46M | 25.49M | 24.53M | 24.58M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 53.91M | 51.12M | 49.26M | 46.63M | 47.11M |
| Operating Income | -21.68M | -19.73M | -18.83M | -18.56M | -20.95M |
| Income Before Tax | -20.78M | -18.90M | -18.13M | -17.97M | -20.61M |
| Income Tax Expenses | 18.00K | 15.00K | 15.00K | 15.00K | 15.00K |
| Earnings from Continuing Operations | -20.79 | -18.91 | -18.15 | -17.98 | -20.63 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -20.79M | -18.91M | -18.15M | -17.98M | -20.63M |
| EBIT | -21.68M | -19.73M | -18.83M | -18.56M | -20.95M |
| EBITDA | -20.84M | -18.75M | -17.91M | -17.74M | -20.21M |
| EPS Basic | -0.75 | -0.70 | -0.69 | -0.71 | -0.83 |
| Normalized Basic EPS | -0.47 | -0.44 | -0.43 | -0.44 | -0.52 |
| EPS Diluted | -0.75 | -0.70 | -0.69 | -0.71 | -0.83 |
| Normalized Diluted EPS | -0.47 | -0.44 | -0.43 | -0.44 | -0.52 |
| Average Basic Shares Outstanding | 110.37M | 108.10M | 105.14M | 102.17M | 99.29M |
| Average Diluted Shares Outstanding | 110.37M | 108.10M | 105.14M | 102.17M | 99.29M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |